Jane Hughes
Chief Tech/Sci/R&D Officer bei GYROSCOPE THERAPEUTICS HOLDINGS PLC
Aktive Positionen von Jane Hughes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01.10.2019 | - |
Karriereverlauf von Jane Hughes
Ehemalige bekannte Positionen von Jane Hughes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Charles River Laboratories, Inc.
 Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA. | Corporate Officer/Principal | 01.07.2017 | 01.11.2018 |
| GSK PLC | Corporate Officer/Principal | 01.09.2014 | 01.06.2017 |
Ausbildung von Jane Hughes
| Keele University | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Charles River Laboratories, Inc.
Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA. | Commercial Services |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Jane Hughes
- Erfahrung
